Amanda Gnecco - Alliance Entertainment Chief Officer
| AENT Stock | 5.50 0.63 12.94% |
Executive
Amanda Gnecco is Chief Officer of Alliance Entertainment Holding
| Age | 44 |
| Address | 8201 Peters Road, Plantation, FL, United States, 33324 |
| Phone | 954 255 4000 |
| Web | https://www.aent.com |
Alliance Entertainment Management Efficiency
The company has return on total asset (ROA) of 0.0283 % which means that it generated a profit of $0.0283 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0548 %, meaning that it created $0.0548 on every $100 dollars invested by stockholders. Alliance Entertainment's management efficiency ratios could be used to measure how well Alliance Entertainment manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.03 in 2024. Return On Capital Employed is likely to gain to 0.1 in 2024. At this time, Alliance Entertainment's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 411.2 M in 2024, whereas Non Current Liabilities Total is likely to drop slightly above 56.9 M in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Deanna MD | Spyre Therapeutics | N/A | |
| Paul JD | Spyre Therapeutics | 59 | |
| April Dovholuk | Centessa Pharmaceuticals PLC | N/A | |
| JD Esq | Centessa Pharmaceuticals PLC | N/A | |
| Peter Miklos | Univest Pennsylvania | N/A | |
| Ryan Crowe | Regeneron Pharmaceuticals | N/A | |
| Christina Chan | Regeneron Pharmaceuticals | N/A | |
| CFE CPA | Spyre Therapeutics | N/A | |
| Scott Burrows | Spyre Therapeutics | 47 | |
| Gerald Underwood | Regeneron Pharmaceuticals | N/A | |
| David Geibel | Univest Pennsylvania | N/A | |
| Nigel Williams | Commonwealth Bank of | N/A | |
| Gregg Pratt | Mind Medicine | N/A | |
| MiRa Huyghe | Spyre Therapeutics | N/A | |
| Eric Conner | Univest Pennsylvania | 53 | |
| Andrew Spencer | Spyre Therapeutics | N/A | |
| Ellie MD | Centessa Pharmaceuticals PLC | N/A | |
| Theresa Fosko | Univest Pennsylvania | N/A | |
| Kelly Boothe | Spyre Therapeutics | N/A | |
| Justin LaFountaine | Spyre Therapeutics | N/A | |
| Bob McCowan | Regeneron Pharmaceuticals | N/A | |
Management Performance
| Return On Equity | 0.0548 | ||||
| Return On Asset | 0.0283 |
Alliance Entertainment Leadership Team
Elected by the shareholders, the Alliance Entertainment's board of directors comprises two types of representatives: Alliance Entertainment inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alliance. The board's role is to monitor Alliance Entertainment's management team and ensure that shareholders' interests are well served. Alliance Entertainment's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alliance Entertainment's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bruce Ogilvie, Executive Board | ||
| Amanda Gnecco, Chief Officer | ||
| Jeffrey Walker, CFO, CEO | ||
| Warwick Goldby, Chief Officer | ||
| Robert Black, Chief Officer | ||
| Ben Means, President Solutions |
Alliance Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Alliance Entertainment a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0548 | ||||
| Return On Asset | 0.0283 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 368.36 M | ||||
| Shares Outstanding | 50.94 M | ||||
| Shares Owned By Insiders | 93.80 % | ||||
| Shares Owned By Institutions | 0.29 % | ||||
| Number Of Shares Shorted | 43.2 K | ||||
| Price To Book | 2.82 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Alliance Stock Analysis
When running Alliance Entertainment's price analysis, check to measure Alliance Entertainment's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alliance Entertainment is operating at the current time. Most of Alliance Entertainment's value examination focuses on studying past and present price action to predict the probability of Alliance Entertainment's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alliance Entertainment's price. Additionally, you may evaluate how the addition of Alliance Entertainment to your portfolios can decrease your overall portfolio volatility.